Which antibiotic wins against superbugs? new study aims to find out
NCT ID NCT06966284
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two strong antibiotics, polymyxin B and colistin, in treating serious infections caused by bacteria that are resistant to many common drugs. Researchers will look at medical records of 480 adults with pneumonia or bloodstream infections to see which antibiotic works better and has fewer side effects. The goal is to give doctors clearer guidance on treating these hard-to-kill infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- polymyxin B and colistin methanesulfonate (antibiotics)
- What this could lead to
- If this study finds one antibiotic works better or is safer, it could help doctors choose the best treatment for serious drug-resistant infections.
- What could go wrong
- This is an observational study, not a controlled experiment, so results may be less reliable. It also looks back at past data, which can have missing or incomplete information.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTEREMIA CAUSED BY GRAM-NEGATIVE BACTERIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tri-Service General Hospital
RECRUITINGTaipei, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.